HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New human papilloma virus E2 transcription factor mimics: a tripyrrole-peptide conjugate with tight and specific DNA-recognition.

AbstractBACKGROUND:
Human papillomavirus (HPV) is the main causative agent of cervical cancer, particularly high risk strains such us HPV-16, -18 and -31. The viral encoded E2 protein acts as a transcriptional modulator and exerts a key role in viral DNA replication. Thus, E2 constitutes an attractive target for developing antiviral agents. E2 is a homodimeric protein that interacts with the DNA target through an α-helix of each monomer. However, a peptide corresponding to the DNA recognition helix of HPV-16 E2 binds DNA with lower affinity than its full-length DNA binding domain. Therefore, in an attempt to promote the DNA binding of the isolated peptide, we have designed a conjugate compound of the E2 α-helix peptide and a derivative of the antibiotic distamycin, which involves simultaneous minor- and major-groove interactions.
METHODOLOGY/PRINCIPAL FINDINGS:
An E2 α-helix peptide-distamycin conjugate was designed and synthesized. It was characterized by NMR and CD spectroscopy, and its DNA binding properties were investigated by CD, DNA melting and gel shift experiments. The coupling of E2 peptide with distamycin does not affect its structural properties. The conjugate improves significantly the affinity of the peptide for specific DNA. In addition, stoichiometric amounts of specific DNA increase meaningfully the helical population of the peptide. The conjugate enhances the DNA binding constant 50-fold, maintaining its specificity.
CONCLUSIONS/SIGNIFICANCE:
These results demonstrate that peptide-distamycin conjugates are a promising tool to obtain compounds that bind the E2 target DNA-sequences with remarkable affinity and suggest that a bipartite major/minor groove binding scaffold can be a useful approach for therapeutic treatment of HPV infection.
AuthorsDiana E Wetzler, Maria J Comin, Krzysztof Krajewski, Mariana Gallo
JournalPloS one (PLoS One) Vol. 6 Issue 7 Pg. e22409 ( 2011) ISSN: 1932-6203 [Electronic] United States
PMID21799846 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • DNA, Viral
  • DNA-Binding Proteins
  • Distamycins
  • E2 protein, Human papillomavirus type 16
  • Oncogene Proteins, Viral
  • Peptide Fragments
  • Pyrroles
  • stallimycin
Topics
  • Amino Acid Sequence
  • Antiviral Agents (chemical synthesis, chemistry, metabolism, therapeutic use)
  • Base Sequence
  • Biomimetic Materials (chemical synthesis, chemistry, metabolism, therapeutic use)
  • DNA, Viral (genetics, metabolism)
  • DNA-Binding Proteins (chemistry)
  • Distamycins (chemistry)
  • Human papillomavirus 16 (physiology)
  • Models, Molecular
  • Molecular Sequence Data
  • Oncogene Proteins, Viral (chemistry)
  • Papillomavirus Infections (drug therapy)
  • Peptide Fragments (chemistry)
  • Protein Structure, Secondary
  • Pyrroles (chemistry)
  • Substrate Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: